Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1169605 | 0.96 | LMNA (0.47) | LMNATHRBCA2 | |
| SCHEMBL4937641 | 0.96 | LMNA (0.47) | LMNATHRBCA2 | |
| SCHEMBL28701223 | 0.96 | LMNA (0.47) | LMNATHRBCA2 | |
| SCHEMBL7626574 | 0.96 | LMNA (0.47) | LMNATHRBCA2 | |
| SCHEMBL6278209 | 0.96 | LMNA (0.47) | LMNATHRBCA2 | |
| SCHEMBL28699116 | 0.96 | LMNA (0.47) | LMNATHRBCA2 | |
| SCHEMBL10534887 | 0.92 | LMNA (0.37) | LMNATHRB | |
| SCHEMBL28420410 | 0.92 | LMNA (0.44) | LMNATHRBCA2 | |
| SCHEMBL64875 | 0.91 | LMNA (0.41) | LMNATHRBCA2 | |
| SCHEMBL9538151 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 832 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3759213-B1 | METHODS, COMPOSITIONS, AND DEVICES FOR ISOLATION AND EXPRESSION ANALYSIS OF REGIONS OF INTEREST FROM A TISSUE | QUANTUMCYTE INC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4720212-A1 | SAFEGUARD AGENT AND USE THEREOF | Li, Haibo (CN) | 2026-04-08 | — | — | EP | claimed |
| US-20250329799-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY | Anthro Energy, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| WO-2025091685-A1 | FLUORINATED LIQUID COMPOSITION AND USE THEREOF | 深圳市鸿富诚新材料股份有限公司 | 2025-05-08 | — | — | WO | claimed |
| US-12227789-B2 | Methods, compositions, and devices for isolation and expression analysis of regions of interest from a tissue | QUANTUMCYTE, INC. (US) | 2025-02-18 | — | — | US | claimed |
| CN-119056001-A | Preparation method and application of dry water-like material and method for preparing composite particle material by using dry water-like material | 中国民航大学 | 2024-12-03 | — | — | CN | claimed |
| WO-2024240215-A1 | SAFEGUARD AGENT AND USE THEREOF | LI HAIBO (CN) | 2024-11-28 | — | — | WO | claimed |
| US-20240390719-A1 | SAFEGUARD AGENT AND USE THEREOF | LI HAIBO (CN) | 2024-11-28 | — | — | US | claimed |
| CN-118272049-A | Cooling medium, preparation method thereof and cooling system | 曙光数据基础设施创新技术(北京)股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118272050-A | Cooling medium, preparation method thereof and immersed cooling system for electronic equipment | 曙光数据基础设施创新技术(北京)股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| US-6191328-B1 | EXTRACTION; PURIFICATION | DAIKIN INDUSTRIES, LTD. (JP) | 2001-02-20 | — | — | US | claimed |
| WO-1999054368-A1 | METHOD FOR PRODUCING POLYPROPYLENE WITH SPECIAL METALLOCENES | TARGOR GMBH (DE) | 1999-10-28 | — | — | WO | claimed |
| CN-1228074-A | Method for purifying 1,1,1,3, 3-pentafluoropropane | DAIKIN IND LTD (JP) | 1999-09-08 | — | — | CN | claimed |
| EP-0921109-A1 | METHOD FOR PURIFYING 1,1,1,3,3-PENTAFLUOROPROPANE | DAIKIN INDUSTRIES, LIMITED (JP) | 1999-06-09 | — | — | EP | claimed |
| WO-1999024016-A1 | EMULSIONS FOR AEROSOLIZATION AND DRUG DELIVERY | SONUS PHARMACEUTICALS, INC. (US) | 1999-05-20 | — | — | WO | claimed |
| US-5206440-A | Oxidation of fluorine containing sulfides to sulfones | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-04-27 | — | — | US | claimed |
| EP-0509034-A1 | HOMOGENEOUS RHENIUM CATALYSTS FOR METATHESIS OF OLEFINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-10-21 | — | — | EP | claimed |
| US-5146033-A | Homogeneous rhenium catalysts for metathesis of olefins | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-09-08 | — | — | US | claimed |
| US-5087710-A | HOMOGENEOUS RHENIUM CATALYSTS FOR METATHESIS OF OLEFINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-02-11 | — | — | US | claimed |
| WO-1991009825-A1 | HOMOGENEOUS RHENIUM CATALYSTS FOR METATHESIS OF OLEFINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1991-07-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240390719-A1 | SAFEGUARD AGENT AND USE THEREOF | BAX, CASP8, BCL2 | LMNA 2980/4885THRB 1883/4885CA2 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.